Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

OrthoCare closing OKC operation

Get in Touch

By Steve Lackmeyer

Copyright © 2013, The Oklahoma Publishing Company

OrthoCare Innovations, a biotech company based at the Presbyterian Health Research Park that once aspired to become a leading prosthetics manufacturer, is set to close the operation and move its headquarters from Oklahoma City to Seattle.

The shutdown will cost eight remaining employees their jobs, all of whom are being offered job placement assistance and severance packages, Chief Executive Officer Doug McCormack said.

“Oklahoma City has been an exceptional partner in the growth of Orthocare Innovations and we give the community the highest recommendation to all of our colleagues in the bioscience sector,” McCormack said. “Recently, we were approached by a large manufacturing entity in this very competitive industry. Therefore, we have entered into a significant strategic relationship with a leading company in the orthotic and prosthetic industry.”

McCormack said details of the new manufacturing operation will be announced in 2014, but added the partnership will provide the company with unmatched manufacturing capability and global distribution. OrthoCare, meanwhile, is set to become a company focused on research operations that are currently performed by its Seattle operation.

OrthoCare Innovations’ operation in Oklahoma City dates to when the company, then based in Seattle and Washington, D.C., bought Martin Bionics in 2008. Martin Bionics at the time acted as a research and development arm for Oklahoma City-based Scott Sabolich Prosthetics and Research. McCormack was a longtime Sabolich patient.

In a 2008 column, McCormack called Oklahoma City a destination of choice for patients worldwide seeking state-of-the-art prosthetic care.

“With a modest investment, Oklahoma could become the national hub for prosthetic device development and commercialization,” McCormack said. “Domestic competition is limited, as most new developments in prosthetics come out of Europe. Today, foreign companies lead prosthetics innovation, and U.S. manufacturers typically produce generic versions of their products. OrthoCare wants to change that, and we think Oklahoma is the perfect home for our ambitious effort.”

Later that year, the Oklahoma City Redevelopment Authority and the Presbyterian Health Foundation negotiated a tax increment financing agreement intended to fund a “mobile incubator” that would accommodate predicted growth at OrthoCare’s Oklahoma City operation.

Mike Anderson, then president of the Presbyterian Health Foundation, said OrthoCare was expected to grow from 15 employees to 115 within the next two years.

“It sounds fast, but they will do it,” Anderson said. “They are that good. They have the right CEO, the right CFO and the right scientists.”

That growth never ensued and OrthoCare paid back job incentives provided by the city.

OrthoCare also received a $1.6 million grant from the state Economic Development Generating Excellence endowment and made Oklahoma City its headquarters.

McCormack, an attorney, maintained his office and residence in Washington, D.C.

A spokesman for OrthoCare said this week the headquarters will be relocated to Seattle as part of the restructuring.

Click here to read the article at newsok.com.

Author

  • admin admin

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E